Director/PDMR Shareholding
September 09 2010 - 6:51AM
UK Regulatory
TIDMGWP
RNS Number : 4255S
GW Pharmaceuticals PLC
09 September 2010
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Porton Down, UK, 8 September 2010: GW Pharmaceuticals (AIM: GWP) hereby provides
notification that the Company has today been notified of the following series of
share transactions entered into by Dr Geoffrey Guy, a Director and Executive
Chairman of the Company.
On 3rd September Dr Guy transferred 8,660 ordinary shares of 0.1p each, equating
to 0.01% of the issued ordinary share capital of the company, into his personal
pension scheme. Dr Guy also sold 1,326 ordinary shares of 0.1p each, equating to
less than 0.01% of the issued ordinary share capital of the company, at the
market price of 103 pence per share. On 6th September Dr Guy sold 25,000
ordinary shares of 0.1p each, equating to 0.02% of the issued ordinary share
capital of the Company, at the market price of 101 pence per share. Dr Guy has
today transferred a further 4,850 ordinary shares of 0.1p each, equating to less
than 0.01% of the issued ordinary share capital, into his personal pension
scheme.
Following this notification Dr Guy retains a beneficial interest in 18,325,115
ordinary shares, amounting to 14.07% of the shares in issue. The total number of
shares outstanding in the Company is 130,210,209 ordinary shares of 0.1p each.
For further information, please contact:
GW Pharmaceuticals PLC +44
(0)1980 557 000
Adam George, Company Secretary
Piper Jaffray Ltd (Nominated Adviser)
Neil Mackison/Rupert Winckler +44 (0)
203 142 8700
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFSIAAIAIII
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Sep 2024 to Oct 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Oct 2023 to Oct 2024